483
Samer Nakhle, M.D.FDA 483 - Samer Nakhle, M.D. - June 30, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Samer Nakhle, M.D. in Las Vegas, NV, a medical research center, identified a significant issue related to the conduct of an investigation. The firm failed to adhere to the investigational plan, specifically regarding subject inclusion criteria. This led to serious consequences, including a subject becoming pregnant and electing to terminate the pregnancy.
Open in Dashboard
ID · 2187d1f2-43f7-4e76-96b9-6deb0e6b690a